Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests, Newsroom

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study.

Neurotheranostics as personalized medicines - ScienceDirect

Full article: The role of the ATP-Binding Cassette A1 (ABCA1) in

Larry Schlossman

Delivering affordable cancer care in high-income countries - The

Pharmacologic Management of Neuropathic Pain

Potential Neuropathic Pain Treatment Shows Promise in Preclinical

Nanotechnology Approaches for Prevention and Treatment of

Potential neuropathic pain treatment shows promise in preclinical

Newsroom & Publications - Cytogel Pharma

Therapeutic potential of conopeptides

Akelos

Full article: State-of-the-art pharmacotherapy for diabetic neuropathy

Anesthesiology